ArticleVeterinary research2026
Cross-protection studies using vGA08 and Mass type IBV vaccines against four different antigenic variant viruses currently circulating in poultry in the USA and Canada.
Article in Veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infectious bronchitis virus (IBV) is a highly contagious gammacoronavirus that causes disease in chickens, typically presenting with respiratory signs but in some cases affecting the reproductive or renal systems. Due to different antigenic variants co-circulating in poultry with limited availability of homologous vaccines, producers have historically combined different vaccine types to provide a broader cross-protective immunity. This study evaluated whether two USDA licensed vaccines (vGA08 and Mass types-administered simultaneously at one day of age) can protect against challenge with 4 different currently circulating variant IBV strains in the US and Canada (PA/1220/98, CA/1737/04, NC/DARK/23, and Canada/DMV1639/23) at 4 weeks of age. For the vaccinated/challenged birds, clinical signs were reduced and the level of challenge virus detected was significantly lowered for each of the challenge viruses compared to non-vaccinated birds challenged with the same virus. This study is important because it provides poultry veterinarians with information on the level protection that can be expected using safe and efficacious commercially licensed vaccines against 4 currently circulating variant IBV strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.